#cancer center pennsylvania

[follow-up-news]

The creeks around East Palestine, Ohio, were so badly contaminated by last year’s disastrous Norfolk Southern derailment that some workers became sick during the cleanup. Workers who reported headaches and nausea — while shooting compressed air into the creek bed, which releases chemicals from the sediment and water — were sent back to their hotels to rest, according to a report obtained by The Associated Press about their illnesses. The findings were not released to the public last spring, despite residents’ concerns about the potential health effects of exposure to the long list of chemicals that spilled and burned after the disaster. The workers’ symptoms, as described in the report, are consistent with what Centers for Disease Control and Prevention workers going door-to-door in town had reported shortly after the Feb. 3, 2023, derailment. Since then some residents have also reported unexplained rashes, asthma and other respiratory problems, and serious diseases including male breast cancer. Researchers are still determining how many of those health problems can be linked to the derailment and how the disaster will impact the long-term health of residents in the area near the Ohio-Pennsylvania border.

[sparviero44]

Charles Bronson

Charles Bronson,

the "death enforcer" died 20 years ago

Childhood in the mine, the name "Soviet" and the burp that started a career, everything you didn't know about the most famous icon with the grim look of cinema

Origins

Charles Dennis Buchinsky was born on November 3, 1921 in Ehrenfeld, Pennsylvania, to parents who immigrated from Lithuania and was the eleventh of fifteen children, all of whom grew up in extreme poverty. In early childhood, Charles did not speak English, but he had to catch up quickly

Early fatigue

When Charles was ten, his father died and the boy followed in his footsteps by getting a job in the mine, like many of his peers, risking his life every day for about a dollar a week. Not too surprising that at that age the future stone face of American cinema was already a smoker.

War

After becoming the first of the Buchinsky family to graduate, in 1943 Charles enlisted in the United States Army and fought in World War II as a pilot in twenty-five aerial missions.

The name

At the beginning of his film career, Buchinsky had to stop for a moment to think about his own name. In the 1950s Senator Joe McCarthy launched a hunt for the alleged Communist who massacred intellectuals and artists across the country on charges of treason and collusion with the Soviet Union. Charles' Lithuanian surname might have made him an easy target, so the aspiring actor took on the all-American name of Bronson.

The first role

For his film debut in 1951's "Commander Johnny" Bronson resorted to a particular skill that no other of the suitors for the role of him had: that of burping on command.

European success

Before becoming an icon of genre cinema in America with "Death Wish" in 1974, Charles had difficulty breaking through in Hollywood, but by the late 1960s he was already a beloved face in Europe, thanks to western films such as “The Guns of San Sebastian” by Henri Verneuil and “Once Upon a Time in the West” by Sergio Leone.

Phobias

As a probable result of a childhood spent underground, Bronson suffered from claustrophobia, but he also had a constant fear of germs and infections, which perfectly explained his notorious aversion to handshakes.

Relations

In 1949 Bronson married colleague Harriet Tendler, with whom he had two children, Suzanne and Tony. The couple divorced in 1965 and three years later the actor returned to the altar with actress Jill Ireland, with whom he remained until her death in 1990 and with whom he had two more daughters, Zuleika and Katarina. Charles' third marriage was in 1998 to Kim Weeks.

The death

Charles Bronson died on August 30, 2003 at Cedars-Sinai Medical Center in Los Angeles after a long hospital stay. The actor had been in failing health since the late 1990s, when he was hospitalized for hip surgery. In the following years, he was also diagnosed with lung cancer and Alzheimer's. His grave is in Brownsville Cemetery in the town of West Windsor, Vermont.

Charles Bronson,

il “giustiziere della notte” moriva 20 anni fa

L’infanzia in miniera, il nome “sovietico” e il rutto che avviò una carriera, tutto quello che non sapevate sull’icona dallo sguardo torvo più famoso del cinema

Origini

Charles Dennis Buchinsky è nato il 3 novembre 1921 a Ehrenfeld in Pennsylvania, da genitori immigrati dalla Lituania e fu l’undicesimo di quindici figli, tutti cresciuti in povertà estrema. Nella prima infanzia, Charles non parlava inglese, ma dovette mettersi in pari alla svelta

Fatica precoce

Quando Charles aveva dieci anni il padre morì e il bambino seguì le sue orme ottenendo un lavoro in miniera, come molti coetanei, rischiando la vita ogni giorno per circa un dollaro a settimana. Non sorprende troppo che a quell’età il futuro volto di pietra del cinema americano fosse già un fumatore.

La guerra

Dopo essere diventato il primo della famiglia Buchinsky a prendere il diploma, nel 1943 Charles si arruolò nell’esercito degli Stati Uniti e combatté nella Seconda Guerra Mondiale come pilota in venticinque missioni aeree.

Il nome

All’inizio della sua carriera cinematografica, Buchinsky dovette fermarsi un attimo a pensare al proprio nome. Negli anni ’50 il senatore Joe McCarthy dette il via a una caccia al presunto comunista che fece strage tra gli intellettuali e gli artisti di tutto il paese con l’accusa di tradimento e collusione con l’Unione Sovietica. Il cognome lituano di Charles avrebbe potuto farne un facile bersaglio, così l’aspirante attore prese il nome tutto americano di Bronson.

Il primo ruolo

Per il suo debutto cinematografico in “Il comandante Johnny” del 1951 Bronson ricorse a una particolare abilità che nessun altro dei pretendenti al ruolo aveva: quella di ruttare a comando.

Successo europeo

Prima di diventare un’icona del cinema di genere in America con “Il giustiziere della notte” del 1974, Charles ebbe difficoltà a sfondare a Hollywood, ma già dalla fine degli anni ’60 fu un volto amatissimo in Europa, grazie a film western come “I cannoni di San Sebastian” di Henri Verneuil e “C’era una volta il West” di Sergio Leone.

Fobie

Come probabile risultato di un’infanzia passata sotto terra Bronson soffrì di claustrofobia, ma ebbe anche un terrore continuo di germi e infezioni, il che spiegava perfettamente la sua nota repulsione per le stette di mano.

Relazioni

Nel 1949 Bronson sposò la collega Harriet Tendler, con la quale ebbe due figli, Suzanne e Tony. La coppia divorziò nel 1965 e tre anni dopo l’attore tornò all’altare con l’attrice Jill Ireland, con la quale rimase fino alla sua morte nel 1990 e con la quale ebbe altre due figlie, Zuleika e Katarina. Il terzo matrimonio di Charles fu nel 1998 con Kim Weeks.

La morte

Charles Bronson morì il 30 agosto 2003 al Cedars-Sinai Medical Center di Los Angeles dopo una lunga degenza. L’attore era ormai di salute cagionevole dalla fine degli anni ’90, quando fu ricoverato per un’operazione all’anca. Negli anni successivi gli furono diagnosticati anche un tumore ai polmoni e l’Alzheimer. La sua tomba si trova al cimitero di Brownsville nella cittadina di West Windsor, Vermont.

[she-is-ovarit]

Hormone Therapy for Gender Dysphoria May Raise Cardiovascular Risks - American College of Cardiology

WASHINGTON (Feb 23, 2023) -

People with gender dysphoria taking hormone replacements as part of gender affirmation therapy face a substantially increased risk of serious cardiac events, including stroke, heart attack and pulmonary embolism, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

Gender dysphoria occurs when a person's gender identity conflicts with the sex they were assigned at birth. Gender affirmation therapy, part of a process known as transitioning, includes a variety of medical, psychological and behavioral interventions to help individuals, many of whom identify as transgender, acquire secondary sex characteristics that align with their gender identity. Recent data suggest about 1 million to 1.6 million people identify as transgender in the U.S. and that hormone therapy use is rising rapidly, especially among teens and young adults.

The current study is the largest to date examining the cardiovascular risks of gender affirmation therapy in this historically understudied population. Previous research on hormone-modulating medications has primarily focused on younger women using hormone-based birth control or on older women following a hysterectomy or during menopause. In these populations, long-term hormone replacement therapy has been associated with an increased risk of breast cancer, stroke and blood clots.

Researchers retrospectively examined rates of cardiovascular events in over 21,000 people with gender dysphoria from a national database of hospital records, of whom 1,675 had used hormone replacement therapy. Typically, people assigned male at birth receive estrogen and people assigned female at birth receive testosterone. Overall results found hormone replacements were associated with higher rates of cardiac events, mostly related to dangerous blood clots, but were not associated with higher rates of death.

"It's all about risks and benefits. Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor," said Ibrahim Ahmed, MD, a third-year resident at Mercy Catholic Medical Center in Darby, Pennsylvania and the study's lead author.

In the study, people with gender dysphoria who had ever used hormone replacements saw nearly seven times the risk of ischemic stroke (a blockage in a vessel supplying blood to the brain), nearly six times the risk of ST elevation myocardial infarction (the most serious type of heart attack) and nearly five times the risk of pulmonary embolism (a blockage in an artery in the lung), compared with people with gender dysphoria who had never used hormone replacements. Hormone replacement therapy was not associated with any increase in deaths from any cause or with increased rates of atrial fibrillation, diabetes, hypertension, hemorrhagic stroke or heart failure.

Both estrogen and testosterone are known to increase the clotting activity of blood, which could explain the increase in clotting-related cardiovascular events, researchers said. Those taking hormone replacement therapy also had higher rates of substance use disorder and hypothyroidism.

"Looking at a person's medical and family history should definitely be part of the screening protocol before they even start hormone replacement therapy," Ahmed said. "It is also important that people considering this therapy are made aware of all the risks."

One limitation of the study is that it only accounted for whether individuals had ever used any type of hormone replacement therapy. To better inform clinical decisions, researchers said it would be helpful to assess whether the duration of treatment, the age at which it is initiated or the type of hormone therapy used affects the risks.

"I'm curious to see if the method of administration alters the outcomes," Ahmed said. "Is one way of giving hormone replacement therapy better or associated with a lower risk of cardiovascular outcomes? If so, then that should be the focus for how we give these patients their hormone replacement therapy going forward."

In addition to considering ways to mitigate potential cardiovascular risks before starting hormone replacement therapy for individual patients, researchers said it will be important to continue to study potential long-term cardiovascular and other health effects of gender affirmation therapies as the use of these therapies become more common.

[mikaishii]

{ Midori Francis, 20, cisfemale, she/her } Is that MIKA ISHII? A SOPHOMORE originally from POTTSTOWN, PENNSYLVANIA, they decided to come to Ogden College to study POLITICAL SCIENCE on an ACADEMIC SCHOLARSHIP. They’re THE ACTIVIST on campus, but even they could get blamed for Greer’s disappearance. 

BASICS

Full name: Mika Ishii Gender: cisfemale Pronouns: she/her Birthday: October 1, 2002 Sexual orientation: homosexual  Zodiac: libra sun, cancer moon, aquarius rising Three positive traits: loyal, optimistic, dedicated Three negative traits: intense, stubborn, emotional Three skills: calligraphy (and, by extension, forgery), drawing (she currently has a webcomic she’s been working on/publishing for two years now), sewing (all of her clothes come from thrift shops and resale, so she’s regularly repurposing and creating new treasures from others’ trash) Extracurriculars: pre-law association, queer alliance, organizer of the woman’s center, animal rights coalition

VIBES

small but scrappy, will start a fight even when she knows she can’t finish it

has been arrested multiple times, lives to be a pain in the ass to any and all authority

has 100% chained herself to a tree

has way too much pride (it’s actually mostly insecurities manifesting in inflated pride but that’s too much to unpack so we just won’t)

mental gymnastics herself into being right no matter what, just try and argue with her, i promise you’ll give up before she does

vegan, but not in an annoying 

she came out to her parents in the middle of her senior year of high school and they’re coming around to it, but more often than not it feels like they just avoid the subject entirely, so mika created the woman’s center because she needed a place to be open and comfortable and safe and knew others would feel the same way

WILL UPDATE MORE AS I GET TO KNOW HER

WANTED CONNECTIONS

the big ex - likely her first real relationship that could have ended on good terms (but bad terms is so much more fun). gimme angst for this one, i’ll leave it all open for plotting

more casual-ish exes 

hookups 

unrequited crush(es) - could go either way !

friends obv

antagonistic relationships 

ALL ! THE ! THINGS !

[mariacallous]

In February, attackers from the Russia-based BlackCat ransomware group hit a physician practice in Lackawanna County, Pennsylvania, that's part of the Lehigh Valley Health Network (LVHN). At the time, LVHN said that the attack “involved” a patient photo system related to radiation oncology treatment. The health care group said that BlackCat had issued a ransom demand, “but LVHN refused to pay this criminal enterprise.” 

After a couple of weeks, BlackCat threatened to publish data stolen from the system. “Our blog is followed by a lot of world media, the case will be widely publicized and will cause significant damage to your business,” BlackCat wrote on their dark-web extortion site. “Your time is running out. We are ready to unleash our full power on you!” The attackers then released three screenshots of cancer patients receiving radiation treatment and seven documents that included patient information.

The medical photos are graphic and intimate, depicting patients' naked breasts in various angles and positions. And while hospitals and health care facilities have long been a favorite target of ransomware gangs, researchers say the situation at LVHN may indicate a shift in attackers' desperation and willingness to go to ruthless extremes as ransomware targets increasingly refuse to pay.

 “As fewer victims pay the ransom, ransomware actors are getting more aggressive in their extortion techniques,” says Allan Liska, an analyst for the security firm Recorded Future who specializes in ransomware. “I think we’ll see more of that. It follows closely patterns in kidnapping cases, where when victims’ families refused to pay, the kidnappers might send an ear or other body part of the victim.”

Researchers say that another example of these brutal escalations came on Tuesday when the emerging ransomware gang Medusa published sample data stolen from Minneapolis Public Schools in a February attack that came with a $1 million ransom demand. The leaked screenshots include scans of handwritten notes that describe allegations of a sexual assault and the names of a male student and two female students involved in the incident.

“Please note, MPS has not paid a ransom,” the Minnesota school district said in a statement at the beginning of March. The school district enrolls more than 36,000 students, but the data apparently contains records related to students, staff, and parents dating back to 1995. Last week, Medusa posted a 50-minute-long video in which attackers appeared to scroll through and review all the data they stole from the school, an unusual technique for advertising exactly what information they currently hold. Medusa offers three buttons on its dark-web site, one for anyone to pay $1 million to buy the stolen MPS data, one for the school district itself to pay the ransom and have the stolen data deleted, and one to pay $50,000 to extend the ransom deadline by one day.

“What’s notable here, I think, is that in the past the gangs have always had to strike a balance between pressuring their victims into paying and not doing such heinous, terrible, evil things that victims don’t want to deal with them,” says Brett Callow, a threat analyst at the antivirus company Emsisoft. “But because targets are not paying as often, the gangs are now pushing harder. It's bad PR to have a ransomware attack, but not as terrible as it once was—and it's really bad PR to be seen paying an organization that does terrible, heinous things.”

The public pressure is certainly mounting. In response to the leaked patient photos this week, for example, LVHN said in a statement, “This unconscionable criminal act takes advantage of patients receiving cancer treatment, and LVHN condemns this despicable behavior.”

The FBI Internet Crime Complaint Center (IC3) said in its annual Internet Crime Report this week that it received 2,385 reports about ransomware attacks in 2022, totaling $34.3 million in losses. The numbers were down from 3,729 ransomware complaints and $49 million in total losses in 2021. “It has been challenging for the FBI to ascertain the true number of ransomware victims as many infections go unreported to law enforcement,” the report notes.

But the report specifically calls out evolving and more aggressive extortion behavior. “In 2022, the IC3 has seen an increase in an additional extortion tactic used to facilitate ransomware,” the FBI wrote. “The threat actors pressure victims to pay by threatening to publish the stolen data if they do not pay the ransom.”

In some ways, the change is a positive sign that efforts to combat ransomware are working. If enough organizations have the resources and tools to resist paying ransoms, attackers eventually may not be able to generate the revenue they want and, ideally, would abandon ransomware entirely. But that makes this shift toward more aggressive tactics a precarious moment. 

“We really haven’t seen things like this before. Groups have done unpleasant things, but it was adults that were targeted, it wasn’t sick cancer patients or school kids,” Emsisoft's Callow says. “I hope that these tactics will bite them in the butt and that companies will say no, we cannot be seen funding an organization that does these heinous things. That’s my hope anyway. Whether they will react that way remains to be seen.”

[rjbaynumphotography]

Babe's 1948 Lincoln Continental Coupe

This was Babe Ruth's last car. The '48 Lincoln Continental Coupe has a V-12 engine; the last V-12 ever produced by a U.S. auto manufacturer. Base retail price for the coupe was then listed at $2,727 about $57,000 today. This was the last time that the Continental name was used for almost a decade.

Then, after an eight-year hiatus, for the 1956 model year, the Continental nameplate made its return; to launch the vehicle, Ford created a namesake "Continental" Division, centered around its new flagship vehicle. To again highlight the European influence of the original Continental, Ford assigned the Mark II suffix to the new Continental (also in an effort to distinguish itself from the similar Bentley Continental. Slotted well above Lincoln-Mercury, Continentals would be marketed and serviced through the new Lincoln dealership network.

Now, the New York Yankees star had more than his share of fender benders over the years, and they apparently had no effect on his thrill for speed, since he continued to purchase customized, powerful automobiles, and then promptly wreck them, or get caught for speeding. He routinely ignored stoplights and traffic signals on the drive from the Astoria Hotel to Yankee Stadium, but police usually let him go with a smile. In July 1920, however, Ruth threw caution to the wind and was lucky to walk away with only an injured knee.

On a road trip to Philadelphia and Washington, Ruth was driving late one night just outside rural Wawa, Pennsylvania, with [his first wife] Helen, and three friends from the club. When he sped dangerously around a curve, the auto skidded out of control. As the machine went off the road, Helen and coach Charley O’Leary were thrown clear as it flipped over. “Crawling from the wreck, Ruth found his wife in fine health, but O’Leary was looking unconscious and dead.

"Oh God, bring Charley back. I didn’t mean it," Babe cried, and O’Leary did in fact turn out to be OK. The car was another story, and after walking to a nearby farm and spending the night, the group returned to the crash site accompanied by a mechanic. ‘Sell it,’ Ruth supposedly said of the wreck. "Take whatever you can get for it. I’m through with it."

Leaving the stunned mechanic and his free parts supply behind, Babe’s party proceeded on to Philadelphia. RUTH REPORTEDLY KILLED IN CAR CRASH read the headline found in one local paper, but Babe was supposedly well enough to purchase a new version of the identical car when he returned to New York. Newspaper accounts did not specify the year, make, and model of the car Ruth was driving; the Sacramento Union referred to it only as a “big touring car.”

The Great Bambino, who retired from baseball in 1935 with a then-record 714 home runs, died from throat cancer 76 years ago on August 16, 1948, nearly three decades after escaping serious injury from a crash while on that road trip.

Nearly three decades after that accident, the Sultan of Swat still loved touring cars. In his final days, he drove this 1948 Lincoln Continental that he received as a gift from Ford Motor Company in appreciation for his tireless support of Little League Baseball. It was the last car he owned. Before becoming too weak to travel, Ruth drove the Lincoln around the country giving speeches and hitting lessons to young baseball players. We know a lot about the beautiful Continental because it was featured in newspapers across the country twice—first when it was given to Ruth and many years later, in 2012, when Texas collector Lonnie Shelton purchased the pristine two-door hardtop coupe from the Texas Museum of Automotive History.

George Herman "Babe" Ruth was born on February 6, 1895, and died on August 16, 1948 - He was only 53.

The top photo was taken after The Ford Motor Company presented it as a gift to the Babe. The bottom one is the car as it is now.

Baseball, Apple Pie, and Lincoln Continental.

[donatomarinelli]

Inflammation Regulation in Lung Cancer Immunotherapy

A recent strategy for treating advanced lung cancer has shown great promise in a small clinical trial led by investigators at the Abramson Cancer Center at the University of Pennsylvania Perelman School of Medicine. A study published recently found that adding an anti-inflammatory drug to anti-PD1 (programmed death-1) checkpoint inhibitor immunotherapy may increase the effectiveness of immunotherapy against advanced lung cancer.

The study involved using a drug known as a JAK1 (Janus kinase 1) inhibitor to decrease chronic inflammation in 21 patients with metastatic NSCLC (non-small-cell lung cancer). The patients took the JAK1 inhibitor for six weeks following two doses of anti-PD1 immunotherapy. The overall response rate was 67 percent, and the median progression-free survival rate was nearly 24 months, both of which are high for advanced NSCLC. The researchers noted that this approach could assist in regulating inflammation and interferon (a protein involved in inflammation) before the levels become toxic. The co-senior authors of the study, Andy Minn and E. John Wherry, pointed out that the patients who benefited most from the trial were those who had low inflammation at the beginning of the study or high inflammation that was reduced by the JAK1 inhibitor.

This study indicates that incorporating an anti-inflammatory drug into immunotherapy is a promising approach to managing advanced lung cancer. The results are quite positive, and the researchers are now preparing for a larger clinical trial to confirm the findings. Such a strategy might potentially assist in managing inflammation and, therefore, enhance the prognosis of patients with metastatic NSCLC.

[dr-mohammed-shahait-01]

Cancer Surgery in Dubai: Expertise of Dr. Mohammed Shahait

Cancer surgery in Dubai has reached advanced levels with the expertise of specialists like Dr. Mohammed Shahait. Dr. Shahait is renowned for his proficiency in managing genitourinary tumors, including kidney, prostate, and bladder cancers. With over 1,500 cases completed, he offers advanced treatments using cutting-edge robotic surgery techniques.

Expertise in Testicular Cancer

Testicular cancer is treated effectively with surgical interventions such as:

Radical Orchiectomy

Radical orchiectomy involves the removal of one or both testicles to eliminate cancer cells. Dr. Mohammed Shahait excels in performing this procedure with precision, ensuring minimal discomfort and a swift recovery.

Retroperitoneal Lymph Node Dissection

In cases where cancer has spread, retroperitoneal lymph node dissection is performed to remove affected lymph nodes. This complex procedure requires the expertise of a seasoned surgeon like Dr. Shahait to ensure optimal outcomes.

Advanced Bladder Cancer Treatments

Bladder cancer treatments offered by Dr. Mohammed Shahait include:

Transurethral Resection of Bladder Tumor (TURBT)

TURBT is a minimally invasive procedure where Dr. Shahait removes bladder tumors using a resectoscope inserted through the urethra. This method is effective for early-stage bladder cancers and ensures a quick recovery.

Partial Cystectomy

For localized tumors, partial cystectomy involves removing only the cancerous part of the bladder. Dr. Shahait’s surgical skills ensure that the bladder's functionality is preserved as much as possible.

Radical Cystectomy with Ileal Conduit or Neobladder

In more advanced cases, a radical cystectomy is performed, where the entire bladder is removed. Dr. Mohammed Shahait offers options like ileal conduit or neobladder reconstruction to maintain urinary function and improve quality of life post-surgery.

Prostate Cancer: Comprehensive Surgical Care

Prostate cancer is the most commonly diagnosed cancer in men, occurring in the small walnut-shaped gland that produces seminal fluid.

Surgical Expertise

Dr. Mohammed Shahait is highly experienced in performing prostate surgeries, ensuring thorough cancer removal while preserving nerve function. His fellowship in advanced robotic surgery at the University of Pennsylvania under Dr. David Lee has equipped him with the skills to perform minimally invasive procedures with high precision.

Credentials and Experience of Dr. Mohammed Shahait

Dr. Mohammed Shahait, M.B.B.S., is a distinguished Urologist in Dubai with significant experience in robotic surgery for genitourinary cancers. His extensive training and previous work experience include:

Consultant of Uro-oncology and Minimally Invasive Surgery, King Hussein Cancer Center, Amman, Jordan

Clinical Instructor of Urology, University of Pennsylvania, USA

Clinical Instructor of Urology, University of Pittsburgh Medical Center, USA

Fellowship in Advanced Robotic Surgery, University of Pennsylvania, USA

Fellowship in Endourology, Laparoscopic and Robotic Surgery, University of Pittsburgh Medical Center, USA

Residency in Urology, American University Hospital, Beirut, Lebanon

Dr. Shahait’s comprehensive training and dedication to minimally invasive surgical techniques make him a leading figure in cancer surgery in Dubai.

Conclusion

For those seeking expert cancer surgery in Dubai, Dr. Mohammed Shahait provides unparalleled care with a focus on patient recovery and quality of life. Whether dealing with testicular, bladder, or prostate cancer, his advanced surgical techniques and extensive experience ensure the best possible outcomes.

[industryinsightsandanalysis]

U.S. Hospice Market: Trends, Drivers, and Future Outlook

The U.S. hospice marketis poised for significant growth, with an anticipated compound annual growth rate (CAGR) of around 8% during the forecast period. Hospice care, a specialized type of care for patients in the terminal phase of their life, emphasizes comfort and quality of life for patients and their families. The burgeoning demand for hospice care is driven by several factors, including the aging population and the rising prevalence of chronic diseases. This article delves into the key market drivers, segmentation, geographic trends, and major players shaping the future of the U.S. hospice market.

Key Market Drivers

1. Aging Population:

The demographic shift towards an older population is one of the primary drivers of the hospice market. The United States is experiencing a significant increase in the geriatric population. According to the United Nations World Population Ageing 2019 report, the 65+ population in the U.S. was 53.3 million in 2019 and is projected to reach 84.8 million by 2050. Older adults are more prone to life-limiting illnesses, thereby increasing the demand for hospice care.

2. Prevalence of Chronic Diseases:

Chronic diseases such as cancer, cardiovascular diseases (CVD), chronic respiratory diseases, and chronic kidney diseases are on the rise. Nearly half of the U.S. adult population has some form of CVD, and by 2035, more than 135 million adults, or 45.1% of the population, are expected to have CVD. Similarly, cancer remains a leading cause of death, with the World Health Organization (WHO) reporting around 2.09 million cases of lung cancer globally in 2018. The rising incidence of these chronic conditions necessitates enhanced hospice care services.

3. Shift towards Home Care:

There is a growing preference for home-based hospice care among patients and families. Home care settings offer a comfortable and familiar environment, personalized care, and a cost-effective alternative to long-term hospital stays. The Centers for Disease Control and Prevention (CDC) reported an increase in the number of hospice care agencies from 4,300 in 2016 to 4,500 in 2018, reflecting this trend.

For a comprehensive analysis of the market drivers, visit: https://univdatos.com/report/u-s-hospice-market/

Market Segmentation

By Diagnosis:

The hospice market is segmented based on the diagnosis into cancer, cardiovascular diseases, chronic respiratory diseases, chronic kidney diseases, and others.

Cancer:

The cancer segment is expected to witness considerable growth due to the increasing number of cancer cases among the elderly population. Advancements in cancer treatments and surgeries further drive the need for hospice care to support patients during their final stages of life.

Cardiovascular Diseases:

The high prevalence of cardiovascular diseases contributes significantly to the hospice market, as patients with severe heart conditions often require end-of-life care.

By Provider:

The market is categorized by provider into hospitals & nursing homes, home care settings, and others.

Home Care Settings:

This segment is anticipated to grow substantially due to the preference for home-based care. Home hospice care allows patients to spend their final days in a familiar environment with their loved ones, supported by professional caregivers.

Geographic Trends

Geographically, the U.S. hospice market is analyzed across major states, including California, Texas, Florida, New York, and Pennsylvania.

California: California holds the largest market share due to its high number of healthcare facilities and treatment options. The states large and growing elderly population, combined with a high prevalence of chronic diseases, drives the demand for hospice care services. The presence of a significant number of hospitals and advanced medical infrastructure further bolsters the market in California.

For a sample report, visit:- https://univdatos.com/get-a-free-sample-form-php/?product_id=22835

Conclusion

The U.S. hospice market is set for robust growth, driven by the aging population, increasing prevalence of chronic diseases, and the shift towards home-based care. With advancements in healthcare and a growing emphasis on quality of life for terminally ill patients, the demand for hospice services is expected to rise significantly. Major market players are continually innovating to meet this demand, ensuring that patients receive compassionate and comprehensive end-of-life care.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411

Website -www.univdatos.com

[wausaupilot]

Aspirus Health adds two oncology clinicians at Medford

MEDFORD –  Aspirus Health recently added two new clinicians to its cancer care services at Aspirus Medford Hospital and Clinic. Thomas Oliver Thomas Oliver, DO, earned his Doctor of Osteopathic Medicine at Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania. He completed an internal medicine fellowship at Lankenau Medical Center, Wynnewood, Pennsylvania, and a Hematology/Oncology…

[sawtelghad]

هل يمكن للكبد أن يحمل علاجا أفضل للسرطان؟ https://sawtelghad.net/71954

[iccaglobal]

Navigating Hope: A Guide to Cancer Treatment with Cancer Treatment Centers of America

The CTCA network spans across the following locations:

Atlanta, Georgia: Nestled in the heart of the South, CTCA in Atlanta combines Southern hospitality with world-class cancer care. Patients have access to a range of services, Cancer Center Of America Locations including advanced radiation therapy, surgical oncology, and integrative oncology therapies. With its convenient location and comprehensive services, CTCA Atlanta serves as a beacon of hope for cancer patients across the Southeast.

Chicago, Illinois: In the bustling city of Chicago, CTCA offers a sanctuary of healing for cancer patients. From innovative treatment options to supportive care services, CTCA Chicago provides a holistic approach to cancer care. Patients benefit from the expertise of renowned oncologists and the latest advancements in cancer research, all within a compassionate and nurturing environment.

Phoenix, Arizona: With its sunny skies and desert landscapes, Phoenix is home to CTCA's Western Regional Medical Center. Here, patients receive personalized cancer treatment in a tranquil setting designed to promote healing and well-being. From state-of-the-art diagnostic imaging to leading-edge therapies, CTCA Phoenix offers hope and healing to patients from across the Southwest and beyond.

Philadelphia, Pennsylvania: As one of the nation's oldest and most historic cities, Philadelphia is also home to CTCA's Eastern Regional Medical Center. Here, patients receive comprehensive cancer care in a supportive and nurturing environment. With a focus on patient-centered care and clinical excellence, CTCA Philadelphia is a trusted destination for cancer treatment in the Northeast.

Tulsa, Oklahoma: Nestled in the heart of the Midwest, CTCA Tulsa offers advanced cancer care in a warm and welcoming setting. Patients benefit from a range of services, cancer centers of america reviews including precision medicine, immunotherapy, and supportive care programs. With its central location and comprehensive services, CTCA Tulsa serves as a beacon of hope for cancer patients across the region.

In addition to these five hospitals, CTCA also operates outpatient care centers and partnerships with other healthcare providers to extend its reach and impact. Through these collaborations, CTCA is able to provide seamless access to cutting-edge cancer care and support services in communities across the country.

[respite-hrh]

The National Harm Reduction Coalition recognizes the Reproductive Justice movement as foundationally important to the Harm Reduction movement. What parallels to harm reduction concepts do you take away from the video above?

Here is an excerpt from an in-depth article on the concept of Reproductive Justice, written by Loretta Ross in 2017 (free download available here: https://www.researchgate.net/publication/322536609_Reproductive_Justice_as_Intersectional_Feminist_Activism

What is Reproductive Justice? In June 1994, twelve black women working in the reproductive health and rights movement birthed the concept of reproductive justice at a pro-choice conference on health care reform in Chicago. We created “reproductive justice” because we believed that true health care for women needed to include a full range of reproductive health services. While abortion is one primary health issue, we knew that abortion advocacy alone inadequately addressed the intersectional oppressions of white supremacy, misogyny, and neoliberalism. From the perspective of African American women, any health care plan must include coverage for abortions, contraceptives, well-woman preventive care, pre- and postnatal care, fibroids, infertility, cervical and breast cancer, infant and maternal morbidity and mortality, intimate partner violence, HIV/AIDS, and other sexually transmitted infections. In simplest terms, we spliced together the concept of reproductive rights and social justice to coin the neologism, “reproductive justice.”

“The 12 women and their affiliations at the time who became the founding mothers of the concept of reproductive justice were: 

Toni M. Bond Chicago Abortion Fund 

Reverend Alma Crawford Religious Coalition for Reproductive Choice 

Evelyn S. Field National Council of Negro Women 

Terri James American Civil Liberties Union of Illinois 

Bisola Maringay National Black Women’s Health Project, Chicago Chapter 

Cassandra McConnell Planned Parenthood of Greater Cleveland 

Cynthia Newbille National Black Women’s Health Project (now Black Women’s Health Imperative) 

Loretta J. Ross Center for Democratic Renewal 

Elizabeth Terry National Abortion Rights Action League of Pennsylvania 

“Able” Mabel Thomas Pro-Choice Resource Center, Inc. 

Winnette P. Willis Chicago Abortion Fund 

Kim Youngblood National Black Women’s Health Project" 

https://www.sistersong.net/

SisterSong is a Reproductive Justice advocacy organization that is fighting for the legal right to bodily autonomy. More information on their advocacy and legal work available on their website (linked above), and on the ACLU website:

WHAT'S AT STAKE

“Georgia physicians, reproductive health care providers, and advocates filed a lawsuit in the Superior Court of Fulton County on June 26, 2022 bringing a state constitutional challenge against H.B. 481, a law banning abortion at approximately six weeks of pregnancy — just two weeks after a person’s first missed period and before many people even know they are pregnant. This lawsuit comes one week after a federal appeals court allowed Georgia’s six-week ban to take effect for the first time since it was passed in 2019, causing an immediate, devastating crisis as clinics were forced to turn away patients in waiting rooms across the state and to cancel many upcoming appointments.”

[bhushans]

Beyond Diagnosis: Exploring Global synthetic biology market

The global synthetic biology market was anticipated to increase at a profitable 23.8% CAGR throughout the forecast period, from US$ 3.75 billion in 2024 to US$ 31.73 billion by 2034. the market is expanding because to the growing demand to improve practical abilities, remodel naturally occurring systems, and create novel biological components, instruments, and systems. Due to the rising demand for bio-based chemicals, renewable fuels, and reasonably priced artificial biology-based drugs and vaccinations, the market for synthetic biology is expanding quickly. The demand for genetically modified crops to feed the world's burgeoning population is driving the synthetic biology market's advancements.

Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1226

At the same time, utmost care needs to be taken to see that government protocols are followed for selling any of the synthetic biology products in the market.

Genetically engineered products, gene synthesis, DNA sequencing, NGS (next-generation sequencing), and bioinformatics are enhancing research in this field of medicine at the global level.

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Synthetic Biology Market’. It has its line of expertise in the form of analysts and consultants to execute using a 360-degree approach in its primary, secondary, and tertiary modes of research.

“With discovery of novel therapeutic targets to treat diseases like cancer on the anvil, the global synthetic biology market is slated to grow voraciously in the upcoming period”, says an analyst from Future Market Insights.

Bioengineering is an interdisciplinary field of science that combines biology and engineering principles to design and build new biological systems or modify existing ones. It involves the application of engineering principles to biological systems, with the goal of creating new and useful functions that are not found in nature.

Key Takeaways

North America holds the largest market share with the US being home to maximum biopharmaceutical and pharmaceutical companies.

Europe holds a significant market share on the back of Germany. This is evident from the fact that Robert Koch Institute, in the year 2019, had 502,655 people based out of Germany diagnosed with cancer. This calls for high-level adoption of synthetic products amongst the Germans.

The Asia-Pacific is expected to be led by China. This could be credited to nigger strategic investment in research in synthetic biology, thereby boosting the bio-economy in the forecast period.

Competitive Biology

Novozymes, in January 2021, did launch Frontia GlutenEx with the objective of assisting wheat processors to increase recovery rate of gluten protein and also cut down on consumption of energy.

Merck, in February 2021, entered into partnership with BioNtech for supplying lipids for manufacturing Pfizer-BioNtech Covid-19 vaccine (BNT162b2).

Merck, in January 2021, completed acquisition of AmpTec to strengthen the product portfolio for manufacturing and developing mRNA to facilitate diagnostics, treatments, and vaccination.

Ribbon Biolabs, in January 2022, did raise a series A financing fund worth EUR 18 Million with the objective of enabling production facilities at the commercial scale along with DNA synthesis technology’s expansion in the US.

GenScript, in November 2021, did expand the gene synthesis production capacities in the US with 100% automated oligo synthesis along with sequencing platforms.

The PABC (Pennsylvania Biotechnology Center), in September 2022, did announce that Thermo Fisher Scientific joined hands as one of the founding sponsors of PABC campus at Doylestown; along with its novel B+Labs incubator in Philadelphia; wherein upcoming life science companies could catalyze the way to commercialization.

Medichem and Bota Bio, in August 2022, did commit to promote sustainability while improvising on industrial processes. The latter’s expertise with respect to enzyme engineering would be used for developing enzymes that could be effortlessly incorporated into former’s chemical processes.

Codexis, in July 2021, along with Kalsec, Inc., did announce expanding research collaboration for manufacturing Kalsec’s natural hop acid.

Key Market Players:

Thermo Fisher Scientific, Inc.

Merck KGaA

Novozymes

Agilent Technologies, Inc.

Codexis, Inc.

Bota Biosciences Inc.

Creative Biogene.

Creative Enzymes.

Enbiotix, Inc.

Illumina, Inc.

Other

Key Segment:

By Product:

Oligonucleotides

Enzymes

Synthetic Cells

Cloning Technologies Kits

Xeno-Nucleic Acids

Chassis Organism

By Application:

Healthcare

Non-Healthcare

By End User:

Biotechnology and Pharmaceutical companies

Academic and Government Research Institutes

Others

[span2023]

Navigating the Pandemic: Masking Requirements Implemented by Philadelphia-Area Health Systems

In response to a surge in respiratory illnesses, including COVID-19 and the flu, several health systems in the Philadelphia area have recently implemented new masking requirements for visitors and staff. This move comes as part of a broader strategy to curb the transmission of respiratory viruses and protect both healthcare workers and the community. This article will delve into the specifics of these requirements, exploring the measures taken by Cooper University Health Care, Jefferson Health, the University of Pennsylvania Health System (UPHS), and Main Line Health.

Cooper University Health Care:

Cooper University Health Care, a prominent healthcare provider in the region, has taken proactive steps to address the increasing number of COVID-19 hospitalizations in Camden, Burlington, and Gloucester counties. Effective January 5, visitors and staff at Cooper University Health Care facilities are mandated to wear masks in patient rooms and exam rooms. The policy extends to all visitors at Cooper University Hospital, requiring them to wear masks. Furthermore, patients and visitors must don masks at all outpatient offices and MD Anderson Cancer Center at Cooper locations. This move reflects the healthcare system's commitment to prioritizing the safety of both patients and healthcare professionals.

Read More